NevadaChronic Care Quality Measures Compared to Achievable Benchmarks
The NHQDR quality measures specific to Chronic Care are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures With No Available Benchmark Information or Supplemental Measures
Short-stay home health patients who had drug education on all medications |
97.3 |
|
|
Tamoxifen or third generation aromatase inhibitor was recommended or administered within 1 year of diagnosis for women with AJCC T1cN0M0 or stage IB to stage III hormone receptor-positive breast cancer |
87.8 |
|
|
Percent of hemodialysis patients whose hemoglobin level is less than 10 g/dL |
18.8 |
|
|
Patients with end stage renal disease due to diabetes |
43.6 |
|
|